Availability of Drugs and Resistance Testing for Bedaquiline, Pretomanid, Linezolid, and Moxifloxacin (Bpal(M)) Regimen for Rifampicin-Resistant Tuberculosis in Europe: Author's Response
                        AuthID
P-016-XX7
                
    P-016-XX7
 
    
                     
    
                    